C
CorMedix Inc.
CRMD · NASDAQ · Healthcare · 592M
Closing price
$7.38
+0.82% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
3.3×
Price / net assetsP/B
1.3×
Enterprise value / EBITDAEV/EBITDA
3.2×
Free cash flow yieldFCF yield
32.5%
Return on equityROE
40.2%
Operating margin
48.2%
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
54.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.